...
search icon
scyx-img

Scynexis Inc Share Price

SCYX
NAQ
$0.8137
+$0.05
(6.58%)
1D
Industry: Pharmaceuticals Sector: Health Care

Scynexis Inc Analyst Forecast

Scynexis Inc Share Price Chart

Scynexis Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$31.89M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
306.13K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.34
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.56 L
$1.31 H
$0.8137

About Scynexis Inc, Common Stock

SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Scynexis Inc Stock Returns

Time FrameSCYXSectorS&P500
1-Week Return1.74%0.72%-1.31%
1-Month Return26.63%1.27%0.78%
3-Month Return40.34%3.13%3.46%
6-Month Return1.4%15.81%6.19%
1-Year Return-23.95%8.89%11.68%
3-Year Return-47.16%20.79%71.21%
5-Year Return-90.43%35.89%74.81%
10-Year Return-98.45%138.44%256.59%

Scynexis Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue12.05M13.16M5.09M140.14M3.75M[{"date":"2020-12-31","value":8.6,"profit":true},{"date":"2021-12-31","value":9.39,"profit":true},{"date":"2022-12-31","value":3.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":2.67,"profit":true}]
Cost of Revenue303.00K312.00K628.00K15.62M-[{"date":"2020-12-31","value":1.94,"profit":true},{"date":"2021-12-31","value":2,"profit":true},{"date":"2022-12-31","value":4.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(303.00K)12.85M4.46M124.52M3.75M[{"date":"2020-12-31","value":-0.24,"profit":false},{"date":"2021-12-31","value":10.32,"profit":true},{"date":"2022-12-31","value":3.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":3.01,"profit":true}]
Gross Margin(2.51%)97.63%87.66%88.85%100.00%[{"date":"2020-12-31","value":-2.51,"profit":false},{"date":"2021-12-31","value":97.63,"profit":true},{"date":"2022-12-31","value":87.66,"profit":true},{"date":"2023-12-31","value":88.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses50.85M73.69M90.22M51.85M40.86M[{"date":"2020-12-31","value":56.36,"profit":true},{"date":"2021-12-31","value":81.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":57.47,"profit":true},{"date":"2024-12-31","value":45.29,"profit":true}]
Operating Income(51.15M)(60.84M)(85.76M)72.67M(37.12M)[{"date":"2020-12-31","value":-70.39,"profit":false},{"date":"2021-12-31","value":-83.72,"profit":false},{"date":"2022-12-31","value":-118.01,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-51.08,"profit":false}]
Total Non-Operating Income/Expense(9.38M)20.95M12.88M(9.66M)17.72M[{"date":"2020-12-31","value":-44.77,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":61.48,"profit":true},{"date":"2023-12-31","value":-46.11,"profit":false},{"date":"2024-12-31","value":84.59,"profit":true}]
Pre-Tax Income(58.33M)(35.95M)(67.51M)67.18M(21.14M)[{"date":"2020-12-31","value":-86.83,"profit":false},{"date":"2021-12-31","value":-53.52,"profit":false},{"date":"2022-12-31","value":-100.49,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-31.46,"profit":false}]
Income Taxes(3.15M)(3.09M)(4.70M)138.00K151.00K[{"date":"2020-12-31","value":-2084.77,"profit":false},{"date":"2021-12-31","value":-2045.03,"profit":false},{"date":"2022-12-31","value":-3112.58,"profit":false},{"date":"2023-12-31","value":91.39,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(55.19M)(32.87M)(62.81M)67.04M(21.29M)[{"date":"2020-12-31","value":-82.32,"profit":false},{"date":"2021-12-31","value":-49.02,"profit":false},{"date":"2022-12-31","value":-93.69,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-31.75,"profit":false}]
Income From Continuous Operations(55.19M)(32.87M)(62.81M)72.20M(21.29M)[{"date":"2020-12-31","value":-76.44,"profit":false},{"date":"2021-12-31","value":-45.52,"profit":false},{"date":"2022-12-31","value":-87,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-29.49,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(55.19M)(32.87M)(62.81M)67.04M(21.29M)[{"date":"2020-12-31","value":-82.32,"profit":false},{"date":"2021-12-31","value":-49.02,"profit":false},{"date":"2022-12-31","value":-93.69,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-31.75,"profit":false}]
EPS (Diluted)(5.15)(1.19)(1.47)1.32(0.44)[{"date":"2020-12-31","value":-390.15,"profit":false},{"date":"2021-12-31","value":-90.15,"profit":false},{"date":"2022-12-31","value":-111.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-33.33,"profit":false}]

Scynexis Inc Ratios

Scynexis Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SCYX
Cash Ratio 4.49
Current Ratio 5.75

Scynexis Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SCYX
ROA (LTM) -28.85%
ROE (LTM) -53.29%

Scynexis Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SCYX
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Scynexis Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SCYX
Trailing PE NM
Forward PE 3.53
P/S (TTM) 10.88
P/B 0.88
Price/FCF NM
EV/R 0.44
EV/Ebitda 0.05
PEG NM

FAQs

What is Scynexis Inc share price today?

Scynexis Inc (SCYX) share price today is $0.8137

Can Indians buy Scynexis Inc shares?

Yes, Indians can buy shares of Scynexis Inc (SCYX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SCYX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Scynexis Inc be purchased?

Yes, you can purchase fractional shares of Scynexis Inc (SCYX) via the Vested app. You can start investing in Scynexis Inc (SCYX) with a minimum investment of $1.

How to invest in Scynexis Inc shares from India?

You can invest in shares of Scynexis Inc (SCYX) via Vested in three simple steps:

  • Click on Sign Up or Invest in SCYX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Scynexis Inc shares
What is Scynexis Inc 52-week high and low stock price?

The 52-week high price of Scynexis Inc (SCYX) is $1.31. The 52-week low price of Scynexis Inc (SCYX) is $0.56.

What is Scynexis Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Scynexis Inc (SCYX) is

What is Scynexis Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Scynexis Inc (SCYX) is 0.88

What is Scynexis Inc dividend yield?

The dividend yield of Scynexis Inc (SCYX) is 0.00%

What is the Market Cap of Scynexis Inc?

The market capitalization of Scynexis Inc (SCYX) is $31.89M

What is Scynexis Inc's stock symbol?

The stock symbol (or ticker) of Scynexis Inc is SCYX

How Can Investors Use Scynexis Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Scynexis Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Scynexis Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Scynexis Inc shares for Indian investors?

When investing in Scynexis Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Scynexis Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Scynexis Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Scynexis Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Scynexis Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top